This property of Mito-CP can be exploited to overcome multidrug resistance evolved by cancer cells against various chemotherapeutic drugs by elevating p-glycoprotein pumping, and MDR and ABCB (ATP-linked drug transporter) protein expression [17–22]. This evidence concerns the gene ABCB1 and cancer.